SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-16-000135
Filing Date
2016-09-21
Accepted
2016-09-21 16:11:36
Documents
18
Period of Report
2016-09-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kaugustmor_09212016.htm 8-K 37042
2 EXHIBIT 99.1 nrxaugustmor.htm EX-99.1 4650
3 nrxaugustmor001.jpg GRAPHIC 95122
4 nrxaugustmor002.jpg GRAPHIC 25825
5 nrxaugustmor003.jpg GRAPHIC 14366
6 nrxaugustmor004.jpg GRAPHIC 110755
7 nrxaugustmor005.jpg GRAPHIC 213270
8 nrxaugustmor006.jpg GRAPHIC 143653
9 nrxaugustmor007.jpg GRAPHIC 94351
10 nrxaugustmor008.jpg GRAPHIC 70505
11 nrxaugustmor009.jpg GRAPHIC 91091
12 nrxaugustmor010.jpg GRAPHIC 145326
13 nrxaugustmor011.jpg GRAPHIC 73751
14 nrxaugustmor012.jpg GRAPHIC 81951
15 nrxaugustmor013.jpg GRAPHIC 165455
16 nrxaugustmor014.jpg GRAPHIC 109924
17 nrxaugustmor015.jpg GRAPHIC 121650
18 nrxaugustmor016.jpg GRAPHIC 127523
  Complete submission text file 0001338095-16-000135.txt   2321119
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 161895753
SIC: 2834 Pharmaceutical Preparations